Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (51-60 of 587) with videos related to

Pageof 59
Sort By:
Journal of Neural Transmission. Supplementum|January 1, 1980
Benign and malignant types of Parkinson's disease: clinical and patho-physiological characterizationW Danielczyk, P Riederer, D Seemann
Journal of Neurology|May 23, 2003
The relevance of preclinical studies for the treatment of Parkinson's diseaseM Gerlach, P Foley, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1978
Changes of some putative neurotransmitters in human cerebral infarctionK Jellinger, P Riederer, P Kothbauer
Acta Neuropathologica|February 20, 1978
Brain monoamines in human cerebral infarcts. A preliminary studyK Jellinger, P Riederer, P Kothbauer
MMW, Munchener Medizinische Wochenschrift|May 30, 1975
Proceedings; Biochemistry of circadian rhythm in endogenous depressionW Birkmayer, E Neumayer, P Riederer
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisisJ Kornhuber, M Weller, P Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Neurotransmission and the ontogeny of human brainW Retz, J Kornhuber, P Riederer
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|March 1, 1996
[Neurotransmitters and ontogenesis of the central nervous system in the human]W Retz, J Kornhuber, P Riederer
Current Medicinal Chemistry|July 29, 2004
Clinical applications of MAO-inhibitorsP Riederer, L Lachenmayer, G Laux
Journal of Neural Transmission. Supplementum|January 1, 1995
Iron-dependent enzymes in Parkinson's diseaseH Reichmann, B Janetzky, P Riederer
Pageof 59

Showing results (51-60 of 587) with videos related to

Sort By:
Pageof 59
Journal of Neural Transmission. Supplementum|January 1, 1980
Benign and malignant types of Parkinson's disease: clinical and patho-physiological characterizationW Danielczyk, P Riederer, D Seemann
Journal of Neurology|May 23, 2003
The relevance of preclinical studies for the treatment of Parkinson's diseaseM Gerlach, P Foley, P Riederer
Journal of Neural Transmission. Supplementum|January 1, 1978
Changes of some putative neurotransmitters in human cerebral infarctionK Jellinger, P Riederer, P Kothbauer
Acta Neuropathologica|February 20, 1978
Brain monoamines in human cerebral infarcts. A preliminary studyK Jellinger, P Riederer, P Kothbauer
MMW, Munchener Medizinische Wochenschrift|May 30, 1975
Proceedings; Biochemistry of circadian rhythm in endogenous depressionW Birkmayer, E Neumayer, P Riederer
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisisJ Kornhuber, M Weller, P Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Neurotransmission and the ontogeny of human brainW Retz, J Kornhuber, P Riederer
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|March 1, 1996
[Neurotransmitters and ontogenesis of the central nervous system in the human]W Retz, J Kornhuber, P Riederer
Current Medicinal Chemistry|July 29, 2004
Clinical applications of MAO-inhibitorsP Riederer, L Lachenmayer, G Laux
Journal of Neural Transmission. Supplementum|January 1, 1995
Iron-dependent enzymes in Parkinson's diseaseH Reichmann, B Janetzky, P Riederer
Pageof 59